For Primary Care & Integrative Medicine

If your practice focuses on prevention, metabolic health, cognitive resilience, or healthy aging, hearing preservation is directly relevant to the care you provide. If your patients are thinking about their hearing, you are in a position to start that conversation years before a specialist sees them.

Why hearing matters in your practice

The Lancet Commission on dementia prevention identified hearing loss as the single largest modifiable risk factor for dementia, ahead of smoking, hypertension, physical inactivity, and social isolation. For practitioners whose clinical framework emphasizes upstream intervention and modifiable risk, hearing preservation is an actionable target.

The challenge is that hearing loss is gradual and invisible. By the time your patients are likely to mention hearing loss, years of inner ear damage have already accumulated. A brief conversation during a wellness visit, a screening question about difficulty hearing in noisy environments, or a simple intake question about noise exposure history can identify patients who would benefit from hearing preservation counseling. You do not need audiometric equipment to start this conversation.

The published evidence

A peer-reviewed real-world evidence study was published in March 2026 in Global Advances in Integrative Medicine and Health.

The key finding: Among 93 adults with diagnosed sensorineural hearing loss who took ACEMg daily, 75.3% maintained or improved their objective hearing test results over two years. In a comparison group of 97 adults who did not take ACEMg, only 26.8% maintained or improved.

The primary outcome measure was distortion product otoacoustic emissions (DPOAEs), an objective test of outer hair cell function performed by audiologists. This is not patient self-report.

Study design: Retrospective observational cohort (real-world evidence), not a randomized controlled trial. The authors acknowledge limitations including absence of randomization, potential for healthy-user bias, and single-practice setting. These limitations are fully disclosed in the published paper.

Open access: The full paper is freely available at pubmed.ncbi.nlm.nih.gov/41884353/. The complete anonymized dataset is at osf.io/9xm4j.

For a more detailed review of the evidence, preclinical research, formulation, safety considerations, and conflict of interest disclosure, see the For Clinicians Overview.

Patient handout

A printable patient handout is available for download. It is written in plain language and includes the published finding, study limitations, common patient questions (cost, insurance, safety, the beta-carotene smoker warning), and links to the full open-access paper and raw dataset. It includes a section for your practice name and notes.

You may reproduce this handout for clinical use without modification.

Wholesale practitioner pricing

Licensed practitioners can access wholesale pricing for in-office dispensing. Professional accounts include volume pricing, patient education materials, and access to clinical support resources.

Direct consumer purchase

Patients may also purchase ACEMg directly at shop.soundbites.com. The current subscription price is $33.99 per four-week supply (two softgels daily).

Questions

For clinical questions, evidence requests, or to discuss how ACEMg fits into your practice:

Email: clinicians@soundbites.com

These statements have not been evaluated by the Food and Drug Administration. ACEMg is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.